BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg + KPV 10 mg

KLOW80 is a multi-component research formulation containing BPC-157 10 mg, GHK-Cu 50 mg, TB-500 10 mg, and KPV 10 mg, developed for experimental investigation of peptide-related pathways associated with tissue homeostasis, cellular repair, and regenerative biology.

BPC-157 is an experimental peptide investigated primarily in preclinical models involving tissue repair, cellular migration, angiogenesis-related signaling, and gastrointestinal and connective-tissue biology.

GHK-Cu (Copper Tripeptide-1) is a copper-binding tripeptide widely studied in connection with collagen biology, fibroblast activity, extracellular matrix (ECM) remodeling, skin homeostasis, and tissue remodeling.

TB-500 is commonly associated with thymosin beta-4-related research and is investigated for mechanisms involving cell migration, cytoskeletal biology, actin regulation, and tissue repair and regeneration.

KPV (Lys-Pro-Val) is an α-MSH-derived tripeptide fragment studied in experimental models involving inflammation-related signaling, immune-cell responses, cytokine regulation, and skin and intestinal biology.

By combining these research molecules, KLOW80 provides an experimental platform for investigating potential multi-pathway interactions among cellular migration, ECM remodeling, inflammatory signaling, and tissue-regeneration mechanisms. Combining the components does not establish that they act synergistically; such interactions require direct experimental validation.

Human clinical evidence for this specific combination remains insufficient. Findings involving individual components or preclinical models should not be interpreted as establishing KLOW80 as a treatment for injuries, wound healing, inflammatory diseases, or other medical conditions.

Livraison standard offerte dès 50 $ vers les États-Unis, le Canada, le Mexique et l'Europe. Expédition sous 1 jour ouvré.

Pas convaincu ? Renvoyez le produit sous 30 jours pour un remboursement intégral, même ouvert.